Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06906627 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Study acronym: IRIS-CKD
StatusRecruiting
PhaseNot applicable
Started2025-10-28
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 33% 750 → 500 participants
See other at-risk trials from Duke University

Amendment history

2026-10-02
Enrollment reduced: 750 → 500 participants
2026-06-15
Study Status, Contacts/Locations v12
Study sites6→7
2026-04-06
Study Status v11
Re-verified, no change to tracked fields
2026-03-13
Study Status, Contacts/Locations v10
Study sitesdetails revised at 1 of 6 sites
2026-02-27
Study Status, Contacts/Locations v9
Study sites5→6
Show 8 earlier versions
2026-01-28
Study Status, Contacts/Locations v8
Study sites4→5
2025-12-05
Study Status, Study Design v7
Enrollment target800→750
2025-11-25
Study Status, Contacts/Locations v6
Study sites4 entries, revised
OchsnerUniversity of Alabama
2025-11-07
Study Status, Contacts/Locations v5
Study sites6→4
2025-11-04
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-10-10→confirmed 2025-10-28
Study sitesdetails revised at 6 of 6 sites
2025-09-16
Study Status, Oversight v3
Primary completion date2026-12-01→2027-04-01
Completion date2026-12-01→2027-04-01
Start date2025-08-01→2025-10-10
2025-07-18
Study Status v2
Primary completion date2026-06-01→2026-12-01
Completion date2026-06-01→2026-12-01
Start date2025-07-01→2025-08-01
2025-05-14
Study Status v1
Start date2025-04-15→2025-07-01
2025-03-25
Original filing
Duke University
455 trials monitored
See 53 trials at risk
Diabetes
4,247 trials monitored
See 176 trials at risk
Type 2 Diabetes
2,082 trials monitored
See 101 trials at risk
Chronic Kidney Disease
1,314 trials monitored
See 54 trials at risk
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Trial Details
NCT Number NCT06906627
Lead Sponsor Duke University
Collaborators: Bayer, Boehringer Ingelheim
Conditions Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM)
Enrollment 500 participants
Start Date 2025-10-28
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-10-01